Original Research
Published on 19 Apr 2023
Factors associated with lipid control in outpatients with heart failure
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1153310
- 1,922 views
- 1 citation
Type at least 3 characters
225 articles
Articles
Editorial
Published on 21 Mar 2023
Editorial: Gut permeability-related endotoxemia and cardiovascular disease: A new clinical challenge
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1118625
- 1,568 views
- 2 citations
Original Research
Published on 02 Mar 2023
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1055069
- 2,060 views
- 5 citations
Brief Research Report
Published on 20 Feb 2023
Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1041457
- 2,112 views
- 2 citations
Review
Published on 16 Feb 2023
Paraoxonase 1 and atherosclerosis
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1065967
- 4,176 views
- 26 citations
Original Research
Published on 08 Feb 2023
The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1065750
- 2,699 views
- 4 citations
Review
Published on 24 Jan 2023
Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1094188
- 4,987 views
- 11 citations
Systematic Review
Published on 19 Jan 2023
Prognostic value of remnant cholesterol in patients with coronary heart disease: A systematic review and meta-analysis of cohort studies
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.951523
- 2,186 views
- 3 citations
Systematic Review
Published on 16 Jan 2023
Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1023651
- 7,626 views
- 22 citations
Original Research
Published on 13 Jan 2023
Associations between endogenous sex hormone levels and adipokine levels in the Multi-Ethnic Study of Atherosclerosis
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1062460
- 2,333 views
- 2 citations
General Commentary
Published on 09 Jan 2023
Commentary: Monocyte and macrophage lipid accumulation results in down-regulated type-I interferon responses
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1086136
- 1,351 views
Original Research
Published on 04 Jan 2023
Bayesian network analysis of panomic biological big data identifies the importance of triglyceride-rich LDL in atherosclerosis development
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.960419
- 6,065 views
- 1 citation
Editorial
Published on 23 Dec 2022
Editorial: Chronic inflammation, oxidative stress and lipoprotein metabolism in cardio-pulmonary continuum
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1055370
- 2,340 views
Original Research
Published on 19 Dec 2022
CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1016126
- 2,624 views
- 2 citations
Original Research
Published on 12 Dec 2022
Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1092331
- 2,891 views
- 8 citations
Original Research
Published on 09 Dec 2022
Mean versus variability of lipid measurements over 6 years and incident cardiovascular events: More than a decade follow-up
in Lipids in Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2022.1065528
- 1,658 views
- 3 citations